Supernus Pharmaceuticals (SUPN) Other Non-Current Assets (2011 - 2026)
Supernus Pharmaceuticals' Other Non-Current Assets came in at $55.02 million for Q2 2026, down 2.5% from the prior quarter.
Powered by 
Analysis
Supernus Pharmaceuticals (SUPN) Other Non-Current Assets (2011 - 2026) Analysis & Trends
At the end of FY2025, Supernus Pharmaceuticals' Other Non-Current Assets was $63.8 million, up 102.4% from FY2024.
- Other Non-Current Assets carries a five-year compound annual growth rate of 8.1% (FY2020 to FY2025).
- Going back by year, Other Non-Current Assets was $31.53 million in FY2024, $39.81 million in FY2022 (-19.1%) and $49.23 million in FY2021 (+13.8%).
- The Q2 2026 figure represents the lowest quarterly Other Non-Current Assets since Q4 2024.
- The fastest year-over-year change in Other Non-Current Assets over five years came in Q1 2023 (growth of 724.3%), and the weakest in Q1 2024 (a decline of 90.5%).
- Business Quant data shows SUPN's Other Non-Current Assets at $56.45 million (Q1 2026), $63.8 million (Q4 2025) and $62.43 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 14.27 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 10.73 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 19.60 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.93 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 12.98 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 4.75 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 9.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Supernus Pharmaceuticals | 2.50 Bn | 1.16 Bn | 185.39 Mn | 55.02 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 55.02 Mn |
| Mar 31, 2026 | 56.45 Mn |
| Dec 31, 2025 | 63.80 Mn |
| Sep 30, 2025 | 62.43 Mn |
| Dec 31, 2024 | 31.53 Mn |
| Jun 30, 2024 | 35.89 Mn |
| Mar 31, 2024 | 38.37 Mn |
| Sep 30, 2023 | 38.82 Mn |
| Jun 30, 2023 | 38.49 Mn |
| Mar 31, 2023 | 403.80 Mn |
| Dec 31, 2022 | 39.81 Mn |
| Sep 30, 2022 | 41.29 Mn |
| Jun 30, 2022 | 47.34 Mn |
| Mar 31, 2022 | 48.99 Mn |
| Dec 31, 2021 | 49.23 Mn |
| Sep 30, 2021 | 40.13 Mn |
| Jun 30, 2021 | 40.69 Mn |
| Mar 31, 2021 | 30.26 Mn |
| Dec 31, 2020 | 43.25 Mn |
| Sep 30, 2020 | 18.32 Mn |
API Access
Supernus Pharmaceuticals Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=SUPN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();